首页> 外文期刊>Biotechnology Research and Innovation >Recovery of recombinant proteins CFP10 and ESAT6 from Escherichia coli inclusion bodies for tuberculosis diagnosis: a statistical optimization approach
【24h】

Recovery of recombinant proteins CFP10 and ESAT6 from Escherichia coli inclusion bodies for tuberculosis diagnosis: a statistical optimization approach

机译:从大肠杆菌包涵体中回收重组蛋白CFP10和ESAT6进行结核病诊断:一种统计优化方法

获取原文
           

摘要

Tuberculosis (TB) is among the top ten causes of mortality worldwide and has high prevalence in developing countries. The dissemination of efficient and low-cost diagnosis tools able to identify its latent form, e.g. the delayed hypersensitivity reaction, is of great importance to accomplish the target of TB eradication. Recent studies have shown the potential of specific Mycobacterium tuberculosis immunodominant antigens, CFP10 and ESAT6, as substitutes of tuberculin skin test. The purpose of this study was to optimize the recovery and purification of recombinant CFP10 and ESAT6 from Escherichia coli inclusion bodies using central composite design. The production of CFP10 and ESAT6 in bioreactor presented yields of 233 and 121?mg?L?1, respectively, after extraction under optimized conditions: biomass concentration of 15?g per 150?mL of sonication buffer, using 12 cycles of disruption and 7 cycles of solubilization, followed by affinity chromatography purification and removal of endotoxins by the micellar method. The identity of the antigens was confirmed by mass spectrometry and their immunoreactivity after recovery and purification was confirmed by Western blot. These results demonstrate the suitability of the preparation methods in the development of a TB diagnosis kit with potential to be diffused in high TB burden countries.
机译:结核病(TB)是全世界死亡的十大原因之一,在发展中国家也很普遍。传播能够识别其潜在形式的有效且低成本的诊断工具,例如迟发型超敏反应,对于实现结核病根除目标具有重要意义。最近的研究表明,特定结核分枝杆菌免疫优势抗原CFP10和ESAT6可以替代结核菌素皮肤试验。这项研究的目的是使用中央复合设计优化从大肠杆菌包涵体的重组CFP10和ESAT6的回收和纯化。在优化的条件下提取后,生物反应器中CFP10和ESAT6的产量分别为233和121?mg?L?1:每15?mL超声处理缓冲液中的生物量浓度为15?g(使用12个破坏周期和7个循环)增溶循环,然后通过胶束法亲和层析纯化和去除内毒素。通过质谱法确认了抗原的身份,并且通过蛋白质印迹法确认了回收和纯化后的免疫反应性。这些结果证明了该制备方法在开发结核病诊断试剂盒中的适用性,并有可能在高结核病负担国家传播。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号